VA GLA netspot
Active Awarded Last action
- Contract number
- 36C26226N0271
- Awardee
-
Novartis Pharmaceuticals Corporation UEI NG61ZA8TADW3
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $160,623
Award facts
- Contract value 100% obligated
- $160,622.70 Current and potential, with all options
- Completion date 80% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Lake Mary, FL 32746, USA
Award details come from SAM.gov/FPDS.
About this award
On January 3, 2026, the Department of Veterans Affairs, Veterans Integrated Service Network 22, awarded a delivery order valued at $160,622.70 to Novartis Pharmaceuticals Corporation for pharmaceutical products to be delivered through March 31, 2026. This firm fixed-price delivery order is issued under Novartis' existing Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB) and does not utilize a small business set-aside designation. The contract will be performed in Lake Mary, Florida, supporting the VA's specialized medical treatment programs, particularly cancer therapies and nuclear medicine products for which Novartis is a primary federal supplier.
This delivery order represents continued procurement activity under Novartis' broader federal contracting relationships with the VA, which include significant indefinite delivery vehicles such as a $7.48 million Blanket Purchase Agreement with VISN 10 for PLUVICTO and a $26.1 billion Defense Health Agency indefinite delivery contract for cancer therapy drugs. Novartis, a foreign-owned pharmaceutical manufacturer headquartered in East Hanover, New Jersey, maintains a substantial federal footprint supplying advanced oncology treatments and radiopharmaceuticals across multiple Veterans Integrated Service Networks and federal healthcare systems.
Quick answers
Who was awarded contract 36C26226N0271?
36C26226N0271 was awarded to Novartis Pharmaceuticals Corporation by Veterans Integrated Service Network 22 (Veterans Health Administration) on January 3, 2026.
How much is contract 36C26226N0271 worth?
The government has obligated $160,623 on 36C26226N0271.
Is contract 36C26226N0271 an order under another contract?
Yes. 36C26226N0271 is a delivery order under 36F79720D0180, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26226N0271 competed?
The extent of competition for 36C26226N0271 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award